The controlled substance market is growing rapidly, driven by trends in oncology and palliative care as well as increased access to treatment for neurological disorders such as ADHD and autism. AMRI is your trusted partner, providing expert solutions for the safe, secure development and manufacture of controlled substances.
We offer a complete suite of capabilities that includes:
- DEA registrations for manufacturing, research and export of Schedule I, II and V controlled substances
- High capacity and flexibility with 3 US manufacturing plants
- Controlled substance vault and DEA manufacturing areas
- Product classes including phenidates, amphetamine derivatives and precursors and opioid precursors
- Proven track record of regulatory compliance for scheduled drugs
- Expert production and containment capabilities
- Access to validated processes and established raw material sources